Lu Hong, Meng Xiaofeng, Yang Chung S
Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, USA.
Drug Metab Dispos. 2003 May;31(5):572-9. doi: 10.1124/dmd.31.5.572.
(-)-Epigallocatechin gallate (EGCG) and (-)-epigallocatechin (EGC) are the major polyphenolic constituents in green tea. In this study, we characterized the enzymology of cytosolic catechol-O-methyltransferase (COMT)-catalyzed methylation of EGCG and EGC in humans, mice, and rats. At 1 microM, EGCG was readily methylated by liver cytosolic COMT to 4"-O-methyl-EGCG and then to 4',4"-di-O-methyl-EGCG; EGC was methylated to 4'-O-methyl-EGC. The K(m) and V(max) values for EGC methylation were higher than EGCG; for example, with human liver cytosol, the K(m) were 4.0 versus 0.16 microM and V(max) were 1.28 versus 0.16 nmol/mg/min. Rat liver cytosol had higher COMT activity than that of humans or mice. The small intestine had lower specific activity than the liver in the methylation of EGCG and EGC. Glucuronidation on the B-ring or the D-ring of EGCG greatly inhibited the methylation on the same ring, but glucuronidation on the A-ring of EGCG or EGC did not affect their methylation. Using EGC and 3,4-dihydroxy-L-phenylalanine as substrates, EGCG, 4"-O-methyl-EGCG, and 4',4"-di-O-methyl-EGCG were all potent inhibitors (IC(50) approximately 0.2 microM) of COMT. The COMT-inhibiting activity of (-)-EGCG-3'-O-glucuronide was similar to EGCG, but (-)-EGCG-4"-O-glucuronide was less potent. The present work provides basic information on the methylation of EGCG and suggests that EGCG may inhibit COMT-catalyzed methylation of endogenous and exogenous compounds.
(-)-表没食子儿茶素没食子酸酯(EGCG)和(-)-表没食子儿茶素(EGC)是绿茶中的主要多酚成分。在本研究中,我们对人、小鼠和大鼠体内胞质儿茶酚-O-甲基转移酶(COMT)催化的EGCG和EGC甲基化的酶学特性进行了表征。在1微摩尔浓度下,EGCG很容易被肝脏胞质COMT甲基化为4”-O-甲基-EGCG,然后再甲基化为4’,4”-二-O-甲基-EGCG;EGC则被甲基化为4’-O-甲基-EGC。EGC甲基化的K(m)和V(max)值高于EGCG;例如,对于人肝脏胞质,K(m)分别为4.0和0.16微摩尔,V(max)分别为1.28和0.16纳摩尔/毫克/分钟。大鼠肝脏胞质的COMT活性高于人或小鼠。在EGCG和EGC的甲基化过程中,小肠的比活性低于肝脏。EGCG的B环或D环上的葡萄糖醛酸化极大地抑制了同一环上的甲基化,但EGCG或EGC的A环上的葡萄糖醛酸化并不影响它们的甲基化。以EGC和3,4-二羟基-L-苯丙氨酸为底物时,EGCG、4”-O-甲基-EGCG和4’,4”-二-O-甲基-EGCG都是COMT的有效抑制剂(IC(50)约为0.2微摩尔)。(-)-EGCG-3’-O-葡萄糖醛酸苷的COMT抑制活性与EGCG相似,但(-)-EGCG-4”-O-葡萄糖醛酸苷的活性较弱。本研究提供了关于EGCG甲基化的基础信息,并表明EGCG可能抑制COMT催化的内源性和外源性化合物的甲基化。